1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Nerve Degeneration in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, G; Carrì, MT; Centonze, D; Cozzolino, M; De Chiara, V; Maccarrone, M; Mercuri, NB; Musella, A; Rossi, S | 1 |
| Bernardi, G; Cavasinni, F; Centonze, D; Cravatt, BF; De Chiara, V; Furlan, R; Lutz, B; Maccarrone, M; Martino, G; Motta, C; Musella, A; Muzio, L; Rossi, S; Studer, V | 1 |
| Baik, HH; Bok, E; Chung, ES; Chung, YC; Jin, BK | 1 |
| Lavie, V; Zalish, M | 1 |
| Gibson, RM; Heenan, L; Molina-Holgado, F; Moore, JD; Pinteaux, E; Rothwell, NJ | 1 |
| Blázquez, C; de Ceballos, ML; Gómez del Pulgar, T; Guzmán, M; Ramírez, BG | 1 |
| Bayçu, C; Civi, K; Durmaz, R; Ozden, H; Ozsandik, A; Sahintürk, V; Shimon, A | 1 |
| Bar-Joseph, A; Belayev, L; Berkovich, Y; Biegon, A; Vered, M | 1 |
| Lavie, G; Leker, RR; Ovadia, H; Shohami, E; Teichner, A | 1 |
9 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Nerve Degeneration
| Article | Year |
|---|---|
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Corpus Striatum; Disease Models, Animal; Dronabinol; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Genotype; Glutamic Acid; Male; Mice; Mice, Mutant Strains; Nerve Degeneration; Neural Inhibition; Neuroprotective Agents; Receptor, Cannabinoid, CB1; Superoxide Dismutase; Superoxide Dismutase-1; Synaptic Transmission | 2010 |
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Corpus Striatum; Dizocilpine Maleate; Dronabinol; Encephalomyelitis, Autoimmune, Experimental; Endocannabinoids; Etanercept; Excitatory Postsynaptic Potentials; Female; Glutamic Acid; Immunoglobulin G; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Neurons; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2011 |
Cannabinoids prevent lipopolysaccharide-induced neurodegeneration in the rat substantia nigra in vivo through inhibition of microglial activation and NADPH oxidase.
Topics: Animals; Antioxidants; Benzoxazines; Cannabinoids; Dronabinol; Lipopolysaccharides; Microglia; Morpholines; NADPH Oxidases; Naphthalenes; Nerve Degeneration; Neurons; Oxidative Stress; Rats; Reactive Oxygen Species; Substantia Nigra | 2012 |
Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury.
Topics: Animals; Axons; Cell Survival; Dronabinol; Excitatory Amino Acid Antagonists; Male; Microscopy, Electron; Nerve Degeneration; Nerve Regeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2003 |
Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling.
Topics: Animals; Cannabinoids; Cells, Cultured; Cerebral Cortex; Dronabinol; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction | 2005 |
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzoxazines; Cannabinoids; Cells, Cultured; Coculture Techniques; Dronabinol; Female; Humans; Injections, Intraventricular; Male; Maze Learning; Microglia; Middle Aged; Morpholines; Motor Activity; Naphthalenes; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitric Oxide; Peptide Fragments; Plaque, Amyloid; Protein Processing, Post-Translational; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Tumor Necrosis Factor-alpha | 2005 |
Dexanabinol prevents development of vasospasm in the rat femoral artery model.
Topics: Animals; Apoptosis; Dronabinol; Endothelial Cells; Femoral Artery; Immunohistochemistry; In Situ Nick-End Labeling; Leukocytes; Male; Microscopy, Electron, Transmission; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Wistar; Subarachnoid Hemorrhage, Traumatic; Vasospasm, Intracranial | 2008 |
Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid.
Topics: Animals; Brain; Brain Edema; Brain Ischemia; Dronabinol; Gerbillinae; Hippocampus; Injections, Intravenous; Ischemic Attack, Transient; Male; Nerve Degeneration; Neurologic Examination; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1994 |
Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia.
Topics: Animals; Body Weight; Brain Ischemia; Cardiovascular Physiological Phenomena; Cerebral Cortex; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Encephalitis; Free Radicals; Infarction, Middle Cerebral Artery; Male; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred SHR; Tetrazolium Salts | 2001 |